Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva vs Vinorelbine in Elderly Advanced NSCLC
NCT01196078Phase 4Completed
- Sponsor
- Roche
- Start
- Feb 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Feb 2007; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01196078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196078.